
Howard Mars
Examiner (ID: 8242)
| Most Active Art Unit | 1206 |
| Art Unit(s) | 1205, 1204, 1208, 1206 |
| Total Applications | 1306 |
| Issued Applications | 954 |
| Pending Applications | 8 |
| Abandoned Applications | 344 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18707547
[patent_doc_number] => 20230330123
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-19
[patent_title] => A NON-AQUEOUS SUSPENSION OF ANTICANCER AGENT
[patent_app_type] => utility
[patent_app_number] => 18/020646
[patent_app_country] => US
[patent_app_date] => 2021-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6588
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18020646
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/020646 | A NON-AQUEOUS SUSPENSION OF ANTICANCER AGENT | Aug 9, 2021 | Pending |
Array
(
[id] => 18626770
[patent_doc_number] => 20230285577
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-14
[patent_title] => POLYSACCHARIDE DERIVATIVE, POLYSACCHARIDE DERIVATIVE-DRUG CONJUGATE, AND METHOD FOR PRODUCING SAME
[patent_app_type] => utility
[patent_app_number] => 18/020993
[patent_app_country] => US
[patent_app_date] => 2021-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40192
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18020993
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/020993 | POLYSACCHARIDE DERIVATIVE, POLYSACCHARIDE DERIVATIVE-DRUG CONJUGATE, AND METHOD FOR PRODUCING SAME | Aug 9, 2021 | Pending |
Array
(
[id] => 17198550
[patent_doc_number] => 20210338644
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-04
[patent_title] => Substituted Fused Imidazole Derivatives and Methods of Treating Sickle Cell Disease and Related Complications
[patent_app_type] => utility
[patent_app_number] => 17/374407
[patent_app_country] => US
[patent_app_date] => 2021-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21675
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17374407
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/374407 | Substituted Fused Imidazole Derivatives and Methods of Treating Sickle Cell Disease and Related Complications | Jul 12, 2021 | Abandoned |
Array
(
[id] => 18692545
[patent_doc_number] => 20230322838
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-12
[patent_title] => DIOSMIN PREPARATION METHOD
[patent_app_type] => utility
[patent_app_number] => 18/004468
[patent_app_country] => US
[patent_app_date] => 2021-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2317
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18004468
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/004468 | DIOSMIN PREPARATION METHOD | Jul 7, 2021 | Pending |
Array
(
[id] => 18552115
[patent_doc_number] => 20230250121
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-10
[patent_title] => METHOD FOR PREPARING GLUCOPYRANOSYL DERIVATIVES AND INTERMEDIATES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/015138
[patent_app_country] => US
[patent_app_date] => 2021-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16860
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18015138
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/015138 | METHOD FOR PREPARING GLUCOPYRANOSYL DERIVATIVES AND INTERMEDIATES THEREOF | Jul 6, 2021 | Pending |
Array
(
[id] => 18522939
[patent_doc_number] => 20230233589
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-27
[patent_title] => METHODS FOR TREATING CANCER USING A MODIFIED MONOSACCHARIDE COMPOUND
[patent_app_type] => utility
[patent_app_number] => 18/011771
[patent_app_country] => US
[patent_app_date] => 2021-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5664
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18011771
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/011771 | METHODS FOR TREATING CANCER USING A MODIFIED MONOSACCHARIDE COMPOUND | Jul 5, 2021 | Pending |
Array
(
[id] => 18522948
[patent_doc_number] => 20230233598
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-27
[patent_title] => Marine Bacterial Exopolysaccharide Derivatives and Uses Thereof in the Treatment of Mucopolysaccharidoses
[patent_app_type] => utility
[patent_app_number] => 18/013346
[patent_app_country] => US
[patent_app_date] => 2021-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11180
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18013346
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/013346 | Marine Bacterial Exopolysaccharide Derivatives and Uses Thereof in the Treatment of Mucopolysaccharidoses | Jun 30, 2021 | Pending |
Array
(
[id] => 17168780
[patent_doc_number] => 20210322450
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-21
[patent_title] => APPLICATION OF COMPOSITION CONTAINING NICOTINAMIDE MONONUCLEOTIDE IN ANTI-AGING DRUGS/HEALTHCARE PRODUCTS
[patent_app_type] => utility
[patent_app_number] => 17/366022
[patent_app_country] => US
[patent_app_date] => 2021-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4883
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17366022
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/366022 | APPLICATION OF COMPOSITION CONTAINING NICOTINAMIDE MONONUCLEOTIDE IN ANTI-AGING DRUGS/HEALTHCARE PRODUCTS | Jun 30, 2021 | Abandoned |
Array
(
[id] => 18725788
[patent_doc_number] => 20230340006
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-26
[patent_title] => DPAGT1 INHIBITORS OF CAPURAMYCIN ANALOGUES AND THEIR ANTIMIGRATORY ACTIVITIES OF SOLID TUMORS
[patent_app_type] => utility
[patent_app_number] => 18/013403
[patent_app_country] => US
[patent_app_date] => 2021-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15944
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18013403
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/013403 | DPAGT1 inhibitors of capuramycin analogues and their antimigratory activities of solid tumors | Jun 29, 2021 | Issued |
Array
(
[id] => 17426091
[patent_doc_number] => 20220053799
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-24
[patent_title] => POSITIVE LATENCY EFFECTS ON COCCIDIOSIS PREVENTION AND TREATMENT VIA ANIMAL FEED
[patent_app_type] => utility
[patent_app_number] => 17/358953
[patent_app_country] => US
[patent_app_date] => 2021-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6141
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17358953
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/358953 | POSITIVE LATENCY EFFECTS ON COCCIDIOSIS PREVENTION AND TREATMENT VIA ANIMAL FEED | Jun 24, 2021 | Pending |
Array
(
[id] => 18581563
[patent_doc_number] => 20230263815
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-24
[patent_title] => SAPONIN CONTAINING EXTRACTS PREPARED FROM HESPERALOE USEFUL IN THE TREATMENT OF NON-HUMAN ANIMALS
[patent_app_type] => utility
[patent_app_number] => 18/011341
[patent_app_country] => US
[patent_app_date] => 2021-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6997
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18011341
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/011341 | SAPONIN CONTAINING EXTRACTS PREPARED FROM HESPERALOE USEFUL IN THE TREATMENT OF NON-HUMAN ANIMALS | Jun 20, 2021 | Pending |
Array
(
[id] => 20246822
[patent_doc_number] => 20250295691
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-09-25
[patent_title] => Silk-Hyaluronic Acid Compositions For Tissue Filling, Tissue Spacing, and Tissue Bulking
[patent_app_type] => utility
[patent_app_number] => 18/002337
[patent_app_country] => US
[patent_app_date] => 2021-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 169927
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18002337
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/002337 | Silk-Hyaluronic Acid Compositions For Tissue Filling, Tissue Spacing, and Tissue Bulking | Jun 18, 2021 | Pending |
Array
(
[id] => 18610848
[patent_doc_number] => 20230277578
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-07
[patent_title] => ORAL DELIVERY OF NICOTINAMIDE ADENINE DINUCLEOTIDE (NAD) AND OTHER NUTRITIONAL SUPPLEMENTS
[patent_app_type] => utility
[patent_app_number] => 18/010324
[patent_app_country] => US
[patent_app_date] => 2021-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2983
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18010324
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/010324 | ORAL DELIVERY OF NICOTINAMIDE ADENINE DINUCLEOTIDE (NAD) AND OTHER NUTRITIONAL SUPPLEMENTS | Jun 17, 2021 | Pending |
Array
(
[id] => 18496106
[patent_doc_number] => 20230218649
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-13
[patent_title] => COMPOSITIONS AND METHODS FOR OVERCOMING MICROENVIRONMENT-MEDIATED RESISTANCE VIA E-SELECTIN TARGETING
[patent_app_type] => utility
[patent_app_number] => 18/001614
[patent_app_country] => US
[patent_app_date] => 2021-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20390
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -43
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18001614
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/001614 | COMPOSITIONS AND METHODS FOR OVERCOMING MICROENVIRONMENT-MEDIATED RESISTANCE VIA E-SELECTIN TARGETING | Jun 10, 2021 | Pending |
Array
(
[id] => 17124311
[patent_doc_number] => 20210299079
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-30
[patent_title] => MONOMETHYL FUMARATE-CARRIER CONJUGATES AND METHODS OF THEIR USE
[patent_app_type] => utility
[patent_app_number] => 17/337595
[patent_app_country] => US
[patent_app_date] => 2021-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46608
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -63
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17337595
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/337595 | MONOMETHYL FUMARATE-CARRIER CONJUGATES AND METHODS OF THEIR USE | Jun 2, 2021 | Abandoned |
Array
(
[id] => 17258431
[patent_doc_number] => 20210371416
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-02
[patent_title] => NOVEL 3,5-DISUBSTITUTED-3H-IMIDAZO[4,5-B]PYRIDINE AND 3,5- DISUBSTITUTED -3H-[1,2,3]TRIAZOLO[4,5-B] PYRIDINE COMPOUNDS AS MODULATORS OF C-MET PROTEIN KINASES
[patent_app_type] => utility
[patent_app_number] => 17/303494
[patent_app_country] => US
[patent_app_date] => 2021-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49693
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17303494
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/303494 | NOVEL 3,5-DISUBSTITUTED-3H-IMIDAZO[4,5-B]PYRIDINE AND 3,5- DISUBSTITUTED -3H-[1,2,3]TRIAZOLO[4,5-B] PYRIDINE COMPOUNDS AS MODULATORS OF C-MET PROTEIN KINASES | May 29, 2021 | Abandoned |
Array
(
[id] => 18466954
[patent_doc_number] => 20230201234
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-29
[patent_title] => FAST DISPERSIBLE PHARMACEUTICAL COMPOSITION COMPRISING CAPECITABINE
[patent_app_type] => utility
[patent_app_number] => 17/927004
[patent_app_country] => US
[patent_app_date] => 2021-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3466
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17927004
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/927004 | FAST DISPERSIBLE PHARMACEUTICAL COMPOSITION COMPRISING CAPECITABINE | May 28, 2021 | Pending |
Array
(
[id] => 18552116
[patent_doc_number] => 20230250123
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-10
[patent_title] => GUT MICROBIOTA BIOACTIVATED PDE4 INHIBITOR PRECURSORS
[patent_app_type] => utility
[patent_app_number] => 17/927827
[patent_app_country] => US
[patent_app_date] => 2021-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23016
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17927827
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/927827 | GUT MICROBIOTA BIOACTIVATED PDE4 INHIBITOR PRECURSORS | May 27, 2021 | Pending |
Array
(
[id] => 18449502
[patent_doc_number] => 20230190778
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => COMPOSITION COMPRISING GLUCOSE OLIGOSACCHARIDE AND PROCESS FOR MAKING THE SAME AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/999613
[patent_app_country] => US
[patent_app_date] => 2021-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10041
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17999613
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/999613 | COMPOSITION COMPRISING GLUCOSE OLIGOSACCHARIDE AND PROCESS FOR MAKING THE SAME AND USE THEREOF | May 27, 2021 | Pending |
Array
(
[id] => 18405796
[patent_doc_number] => 20230167147
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-01
[patent_title] => METHOD OF PRODUCING ALIPHATIC GLYCOSIDE COMPOUND OR SUGAR FATTY ACID ESTER COMPOUND
[patent_app_type] => utility
[patent_app_number] => 17/927616
[patent_app_country] => US
[patent_app_date] => 2021-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8649
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17927616
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/927616 | METHOD OF PRODUCING ALIPHATIC GLYCOSIDE COMPOUND OR SUGAR FATTY ACID ESTER COMPOUND | May 27, 2021 | Pending |